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Background: The use of potentially inappropriate medications (PIM) among the elderly is a serious public health
problem because it is intrinsically linked to increased morbidity and mortality, causing high costs to public health
systems. This study’s objective was to verify the prevalence of and the factors associated with the use of PIMs by
elderly Brazilians in institutional settings.
Methods: We performed a transversal study, by consulting the case files of elderly people living in Long Term Care
for the Elderly (LTC) in towns in the State of São Paulo, Brazil, as well as structured interviews with the nurses
responsible for them.
We identified PIMs using the list of recently updated Beers criteria developed by a group of specialists from the
American Geriatrics Society (AGS), who reviewed the criteria based on studies with high scientific evidence levels.
We defined the factors studied to evaluate the association with PIM use prior to the statistical analyses, which were
the chi-square test and multiple logistic regression.
Results: Among the elderly who used drugs daily, 82.6% were taking at least one PIM, with antipsychotics (26.5%)
and analgesics (15.1%) being the most commonly used. Out of all the medications used, 32.4% were PIMs, with
29.7% of these being PIMs that the elderly should avoid independent of their condition, 1.1% being inappropriate
medication for older adults with certain illnesses or syndromes, and 1.6% being medications that older adults
should use with caution. In the multivariate analysis, the factors associated with PIM use were: polypharmacy
(p = 0.0187), cerebrovascular disease (p = 0.0036), psychiatric disorders (p < 0.0001) and dependency (p = 0.0404).
Conclusions: The results of this study showed a high prevalence of PIM use in institutionalized elderly Brazilian patients.
and the associated factors were polypharmacy, psychiatric disorders, cerebrovascular diseases and dependency.
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The elderly’s use of inappropriate medications is a ser-
ious public health problem because it is intimately re-
lated to adverse drug reactions [1,2], and these, in turn,
lead to an exceptional increase in indices of morbidity
and mortality, generating wasted health resources [3],
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(PIMs) has been studied in different health care scenar-
ios, and despite the wide range of information on the
subject, health professionals continue to prescribe many
PIMs to the elderly. The use of PIMs among residents of
long-term care for the elderly (LTC)—which, according
to Morais [5], consist of groups of elderly people with
particularly high uses of medications differs according to
the countries where the studies have been performed. In
Japan, Niwata et al. [6] found a PIM use rate of 21.1% in
LTC, which included not only nursing homes, but also
other institutions, such as hospitals and elderly cared. This is an Open Access article distributed under the terms of the Creative
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residents in an LTC was 32.7% [1].
In a review of studies performed in LTCs in Europe
and the United States, Gallagher et al. [7] found a preva-
lence of 40%.
After an extensive review of the existing literature, we
found only one study performed in a Brazilian LTC by
Castellar et al. [8], who found a PIM use prevalence of
46.2%.
Holistic therapeutic care, including pharmaceutical
care, is an area of interest for the Brazilian Public Health
System (Sistema Único de Saúde [SUS]), which plays an
essential role in guaranteeing access to medication for
the whole population [9]. However, according to Gomes
and Caldas [10], medical professionals in Brazil lack
knowledge about prescribing PIMs to the elderly. In
addition, the fact that the SUS does not have the most
adequate medications for the elderly regularly available
increases the risk of inappropriate medications being
given to this group.
The Beers Criteria are used to classify and describe the
risks related to these medications [11-13]. For 20 years,
the Beers Criteria list has been the most widely
consulted list for evaluating the prescription of medica-
tion to the elderly [14,15].
However, these criteria must be updated regularly to
reflect newly launched medications and the publication
of new evidence related to the use of these medications.
As a result, a multidisciplinary panel of specialists
(American Geriatrics Society [AGS]) after a rigorous sys-
tematic review, recently updated and expanded the cri-
teria [16].
The medications included in the new list are
subdivided into three main categories: 34 medications
that are potentially inappropriate because they have a
high risk of adverse reactions or are of limited effective-
ness in the elderly; 14 medications that are potentially
inappropriate for elderly people with certain pathologies
and/or syndromes since they can exacerbate the pre-
existing disease/syndrome; 14 medications that should
be used with caution by the elderly. These medications
can be associated with greater risk than benefit in the
elderly [16]. In light of this situation, the main objectives
of this study were to verify the prevalence of prescribing
inappropriate medications to the elderly by using the
updated Beers Criteria and to determine what factors




We performed a transversal study by consulting the files
of elderly residents of care homes, with an age of ≥60 years
and through structured interviews with the nursesresponsible for the elderly residents in these institutions
during the period from December 2011 to May 2012.
We applied an age limit of 60 years for the sample
participants. This age limit is justified because in devel-
oping countries, such as Brazil, the World Health
Organization (WHO) [17] considers people to be eld-
erly when they are 60 years or older. This threshold dif-
fers from that in developed countries, where the age
limit is 65 years or above. Moreover, in Brazil, certain
legal measures describe the elderly population based on
this age range [18,19].
We performed data collection in four towns in the
state of São Paulo, Brazil. Three of these towns were
large (population between 100,000 and 900,000 inhab-
itants) and one was medium sized (population be-
tween 50,001 and 100,000 inhabitants) [20]. The
selection of towns was by convenience. To obtain a
more homogenous sample, the study population in-
cluded all of the elderly people living in all six of the
LTCs in these four towns.
We excluded people who had not yet reached 60 years
of age during the data collection period, those who did
not fully reside at the institution, and those who died
during this period.
The six institutions housed elderly people with the
same socio-economic characteristics. The majority of the
population was illiterate, had a low educational level,
and had retired on a low income.
Data was obtained by documentary analysis of the
medical records of the elderly residents, complemented
by interviews with the nurses responsible for each LTC.
For the interviews, we used a previously tested struc-
tured questionnaire with open and closed questions, and
we recorded the following data: social characteristics
(age, household income, educational level) and questions
related to health, such as hospital admissions during the
year, pathologies, symptoms or syndromes present, as
well as a diary of the medications prescribed (name of
medication, indication for medication, and symptoms
after taking the medication). We also recorded data that
evaluated the dependency level, using the Katz Index
[21], which was applied to all the medical records.
During the month prior to data collection, all the
medical drugs prescribed were collected, during which
all standard information contained in the records was
registered and the daily prescription charts or prescrip-
tions for each resident reviewed, complemented when
necessary by information from the packaging and leaflets
provided. All industrial medical drugs and master for-
mulas were included in the database and analyzed, ex-
cept for those whose composition could not be clearly
determined (homeopathics, phytotherapies and teas).
The medications were classified into therapeutic cat-
egories, according to their principle active agent(s), using
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tem (ATC) as a reference [22].
Medications that had more than one principle active
agent were placed in the therapeutic category of the
main principle agent; products with different pharmaco-
logical actions were classified taking into consideration
the condition for which they were prescribed or used, as
described by Coelho Filho, Marcopito, and Castelo [23].
Ethics
This study was performed in compliance with the
Helsinki Declaration and was approved by the Research
Ethics Committee of UNESP- the State University of São
Paulo (Universidade Estadual Paulista).
Variables studied
Dependent variable
The dependent variable was the use of at least one in-
appropriate medication by the elderly, defined as the
daily use of medications that have been described by the
recently updated Beers criteria [16].
With updates to the Beers Criteria, certain medica-
tions from the previous list were excluded [18] because
no studies based on plausible evidence showed them to
be potential causes of adverse reactions in the elderly.
On the other hand, other drugs were included and
presented as inappropriate medications for use in the
elderly, based on the evidence of new studies or because
they were recently launched in the market.
Thus, medications inappropriate for the elderly found
by the study were classified as “medications the elderly
should avoid, independent of their diseases and condi-
tions”, “medications inappropriate for the elderly with cer-
tain diseases or syndromes”, and “medications that should
be used with caution”, as proposed by the AGS [16].
To classify medications as “medications inappropriate
for the elderly with certain diseases or syndromes”, we ex-
amined the records of each senior citizen and the condi-
tions found, duly identified according to the International
Classification of Diseases, Version 10 (ICD-10) [24].
We should emphasize that not all of the medications
on the Beers list are available in Brazil. Therefore, we
evaluated and classified only those medications sold in
the country, which were used by the institutionalized
elderly participants and included in the updated list.
Independent variables
Sociodemographic variables and the variables related
to health obtained were categorized for the purposes of
statistical analysis. Age was categorized as: ≥ 75 and < 75
and hospital admissions as: yes/no, depending on whether
the person had or had not been hospitalized during the
year prior to the research;We identified polymorbidity when a patient had four
or more diseases [25], and categorized it as follows: no
(0–3 diseases) and yes (≥4 diseases).
We measured the dependency level of the elderly
using the scale designed by Katz et al. [21] as follows:
“dependent” (elderly classified as “dependent” or “par-
tially dependent” by the scale) and “non-dependent”
(elderly classified as “independent” by the scale).
We determined polypharmacy by counting the num-
ber of medications in use, with a cutoff point of ≥5 med-
ications, as other authors have done [26-28].
An elderly person with a diagnosis of schizophrenia,
oligophrenia, or Alzheimer’s disease was considered to
have a psychiatric disorder. Cerebrovascular diseases in-
cluded: epilepsy, CVA sequlae, paraplegia, and atrophy
of the limbs.
Elderly people were classified as having depression
when the institution’s medical team had made this diag-
nosis and when they were receiving treatment for this
pathology.
Statistical analysis
Univariate analyses were performed to describe the cat-
egorical variables and factors associated with the use of
medications inappropriate for the elderly. P-values were
generated using the Chi-square association test and
Fisher’s exact test.
Next, we performed a multivariate logistic regression
model, including in the model any variables with values
lower than or equal to 20% in the univariate analysis,
which were dependency, polypharmacy, polymorbidity,
depression, cerebrovascular disease, psychiatric disor-
ders, and diabetes mellitus.
Through this analysis, we obtained the values for the
odds ratio (OR), and the significance level adopted
was 5%.
All analyses were conducted using Biostat statistical
software (version 5.3; Mamirauá Institute for Sustainable
Development) [29].
Results
Out of a total of 268 elderly identified, 3 did not fully
reside at the institution (they were there only during the
day and returned to their homes at night), and 4 would
not yet be 60 years of age within the study period; the
remaining 261 were enrolled as participants. Additional
file 1: Table S1 shows the characteristics of the partici-
pants in this study. Of these, (96.9%) used medication
continuously, with an average of 5.7 medications used
per day.
The 1452 medications prescribed to this study’s elderly
involved 215 different active principles, the majority of
which (35.3%) affected the central nervous system
(CNS). Figure 1 shows the medications the participants
Figure 1 Pharmacological groups of medications prescribed to
residents of care facilities, classified according to the location
of action. CNS = central nervous system; GIS = gastrointestinal
system; CVS = cardiovascular system; BS = blood system; RS =
respiratory system; MSS = musculoskeletal system; IS =
immune system.
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peutic subgroups.
In terms of the inappropriate use of medication,
82.6% of the elderly who used medication on a daily
basis received a minimum of one medication that was a
PIM, with antipsychotics (26.5%) and analgesics (15.1%)
being the most frequently used therapeutic categories
(Additional file 2: Table S2).
Anxiolytics (12.5%), antiarrythmics (7.2%), and antide-
pressants (6.8%) were found in more than 30 prescrip-
tions (Additional file 2: Table S2).
Out of all the medications prescribed and used, 32.4%
were PIMs for the elderly. This percentage was divided
into the three categories proposed by the AGS as fol-
lows: 29.7% PIMs for use by the elderly, independent of
any diagnosis; 1.1% medications that were counter-
indicated for the elderly with certain pathologies or syn-
dromes; and 1.6% medications that should be used with
caution by the elderly (Additional file 2: Table S2).
To analyze associations, we considered the use of at
least one medication inappropriate for the elderly.
Our univariate analysis revealed a significant associ-
ation between PIM use and polypharmacy (p ≤ 0.0001),
polymorbidity (p ≤ 0.0001), psychiatric disorders (p ≤
0.0001), depression (p = 0.0204), cerebrovascular disease
(p = 0.0048), diabetes mellitus (p = 0.0108) and depend-
ency (p=0.1737) (Additional file 3: Table S3).
Applying multivariate analysis, we observed that the
variables of polypharmacy (p = 0.0187), psychiatric dis-
orders (p ≤ 0.0001), cerebrovascular disease (p = 0.0036)
and dependency (p=0.0404) were associated significantly
with reports of PIM use. However, the variables of
polymorbidity, depression and diabetes mellitus lost
their significance at this stage of analysis, as the data in
Additional file 3: Table S3 shows.Discussion
The main results of this study demonstrate a high preva-
lence for PIM use among elderly Brazilians in institu-
tions, with a predominance of antipsychotics among the
therapeutic classes of medications used. We found an
association with polypharmacy, a factor consistently
reported in the literature. However, certain specific con-
ditions such as psychiatric disorders, dependency, and
cerebrovascular diseases were associated factors that we
identified for the first time.
Use of medications
The average consumption of medications used daily by
the present study, although it may look high, is actually
lower than that of other studies [30-33]. However, in
terms of the prevalence of medicines identified as in-
appropriate, the result observed was potentially high
(82.6%).
In terms of the most commonly used therapeutic clas-
ses, we observed a predominance of medications acting
on the central nervous system (35.3%), with antipsy-
chotics (26.5%) and analgesics (15.1%) being the PIMs
most frequently used. These findings corroborate the re-
sults of Mann et al. [34] and Fortselund et al. [35]. The
predominant use of antipsychotics among the residents
of LTCs reflects the high number of older adults affected
by mental or behavioral disorders, as reported by Con-
verso and Iartelli [36] and Lenardt et al. [37]. It is to be
expected that these disorders are among the main path-
ologies of residents of LTCs because these elderly people
require more care and more time dedicated to them.
Therefore, family members end up placing them in
LTCs.
Factors associated with PIM use
We observed a clear association between PIM use and
polypharmacy, but not with age, sex, or hospital admis-
sions. Wahruch et al. [25] and Ruggiero et al. [38]
reported the same findings. Moreover, numerous studies
in the literature [1,32,38-41] have demonstrated a signifi-
cant relationship between polypharmacy and PIM use.
As Bao et al. [41] noted, it is not surprising that
polypharmacy is a factor strongly associated with PIM
use since patients taking many medications have a better
chance of receiving an inappropriate prescription and
are more likely to have multiple pathologies, hospitaliza-
tions, and consultations with multiple doctors of various
specialties, which could lead to prescriptions of PIMs.
Elderly people with cerebrovascular disease and psy-
chiatric disorders have 7.3 and 5.3 times higher chances
of using PIMs, respectively, than those unaffected by
these illnesses.
According to Wawruch et al. [25], the association be-
tween PIM use and certain pathologies could be an
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a tendency for irrational prescriptions. This finding
shows the importance of understanding what conditions
or factors are associated with using inappropriate medi-
cation, as having this knowledge makes it possible to
evaluate the quality of the health care provided.
Another factor associated with PIM use, according to
this study’s results, was dependency. Dependent elderly
people do not practice activities, not simply physical ac-
tivities, but also basic and routine activities, which can
affect their quality of life; this fact may explain this
association.
As a result, this situation can lead to pathologies, such
as circulatory disturbances. In addition to these diseases,
we verified that polymorbidity occurs in these cases,
which in turn leads to a greater consumption of medica-
tion and increases the likelihood of receiving an inappro-
priate prescription, as noted above.
Strengths of the study and implications for the Brazilian
health system
The results of this study are relevant, above all, because
there is a dearth of knowledge about pharmacotherapy
for elderly Brazilians living in institutions. In addition to
addressing a theme about which little is known in Brazil,
this study is the first to examine the factors that might
influence PIM use in Brazilian LTCs.
We also want to emphasize that this study is one of
the first studies to evaluate the use of medications in-
appropriate for the elderly using the revised Beers cri-
teria [16], and to identify new risk factors for the use of
PIMs.
The Beers Criteria list is an indispensible tool to verify
the use of inappropriate medications by the elderly and
to prevent side effects caused by using inappropriate
medications. As a consequence, the use of this tool
would reduce the expense of public funds used to fi-
nance the health care service (SUS).
Moreover, the results of this study indicate the need to
train health professionals responsible for caring for eld-
erly Brazilians living in institutions, given the high
prevalence of PIM use.
This result may offer a possible explanation for why
Brazilian hospitals and emergency institutions are so
overcrowded, given that the PIMs used by 82.6% of the
elderly in this study have more risks than benefits and
are associated with serious side effects, which are
responsible for 10 to 20% of acute hospital admis-
sions [42].
In addition, these results can help administrators and
health professionals at these institutions to evaluate their
health services, especially pharmacotherapy. Based on
these data, it is possible to plan measures to improve
medical prescribing in LTCs.Limitations of the study
One of the limitations of this study is the fact that the
results cannot be generalized to other countries. More-
over, the results are not representative of the elderly liv-
ing in LTCs in other parts of Brazil, especially the
poorest regions. Thus, it is fundamental that additional
studies be performed to determine not only the preva-
lence of inappropriate prescribing, but also its impact on
morbimortality within the elderly, especially those in
institutions.
Another limitation of this study arises from the fact
that the updated Beers list was only recently published.
As a result, health professionals may not have had suffi-
cient time to adapt to new scientific evidence. Thus, we
need to perform further studies with the same methodo-
logical design to verify whether there have been im-
provements in prescribing appropriate medications to
the elderly.
Moreover, we suggest that there should be studies that
adapt the updated Beers Criteria to medication available
in Brazil. Using the previous Beers-Fick [13] Criteria list,
Gorzoni et al. [14] verified that the criteria did not cover
all situations involving PIM use in elderly Brazilians.
These criteria do not include drugs in common use in
Brazil, such as antitussives, cinnarizine, diltiazem, pirace-
tam, quinolones, xanthines, creams, pomades, and eye-
washes that should be prescribed with caution to the
elderly. As an example, we cite the pharmacological ac-
tion of certain eyewashes, which may lead to cardiovas-
cular changes and psychiatric disorders in elderly patients
[43,44]. Thus, the prevalence of PIM use in this study,
although extremely high, may still be underreported.Conclusions
This study’s results indicated that there is a high preva-
lence of PIM use among elderly Brazilians living in insti-
tutions, with medications acting on the CNS being the
most common group of drugs in use, a circumstance
which fits with the high percentage of elderly people
who have mental health problems.
We also observed that polypharmacy was a main fac-
tor associated with PIM use in residents of institutions,
a finding which reflects the multiple pathologies present,
and the prevalence of psychiatric disorders, cerebrovas-
cular disease, and dependency.Additional files
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